220 related articles for article (PubMed ID: 35887187)
1. A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer.
Elhasnaoui J; Ferrero G; Miano V; Franchitti L; Tarulli I; Coscujuela Tarrero L; Cutrupi S; De Bortoli M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887187
[TBL] [Abstract][Full Text] [Related]
2. Splicing factor
Gökmen-Polar Y; Neelamraju Y; Goswami CP; Gu Y; Gu X; Nallamothu G; Vieth E; Janga SC; Ryan M; Badve SS
EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30665944
[TBL] [Abstract][Full Text] [Related]
3. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.
Ishii H; Saitoh M; Sakamoto K; Kondo T; Katoh R; Tanaka S; Motizuki M; Masuyama K; Miyazawa K
J Biol Chem; 2014 Oct; 289(40):27386-99. PubMed ID: 25143390
[TBL] [Abstract][Full Text] [Related]
4. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
[TBL] [Abstract][Full Text] [Related]
5. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
Vadlamudi Y; Dey DK; Kang SC
Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
Fici P; Gallerani G; Morel AP; Mercatali L; Ibrahim T; Scarpi E; Amadori D; Puisieux A; Rigaud M; Fabbri F
Oncotarget; 2017 Jan; 8(2):2423-2436. PubMed ID: 27911856
[TBL] [Abstract][Full Text] [Related]
7. Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients.
Liu X; Wang Q; Song S; Feng M; Wang X; Li L; Liu Y; Shi C
Med Sci Monit; 2021 Jul; 27():e931102. PubMed ID: 34262011
[TBL] [Abstract][Full Text] [Related]
8. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.
Shapiro IM; Cheng AW; Flytzanis NC; Balsamo M; Condeelis JS; Oktay MH; Burge CB; Gertler FB
PLoS Genet; 2011 Aug; 7(8):e1002218. PubMed ID: 21876675
[TBL] [Abstract][Full Text] [Related]
9. Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
Zhao Y; Li M; Wu W; Miao W; Liu H
Front Immunol; 2023; 14():1161273. PubMed ID: 37090731
[TBL] [Abstract][Full Text] [Related]
10. Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.
Yao J; Caballero OL; Huang Y; Lin C; Rimoldi D; Behren A; Cebon JS; Hung MC; Weinstein JN; Strausberg RL; Zhao Q
Cancer Immunol Res; 2016 Jun; 4(6):552-61. PubMed ID: 27045022
[TBL] [Abstract][Full Text] [Related]
11. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
Göttgens EL; Span PN; Zegers MM
Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
[TBL] [Abstract][Full Text] [Related]
12. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
13. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
Horiguchi K; Sakamoto K; Koinuma D; Semba K; Inoue A; Inoue S; Fujii H; Yamaguchi A; Miyazawa K; Miyazono K; Saitoh M
Oncogene; 2012 Jun; 31(26):3190-201. PubMed ID: 22037216
[TBL] [Abstract][Full Text] [Related]
14. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
Freytag M; Kluth M; Bady E; Hube-Magg C; Makrypidi-Fraune G; Heinzer H; Höflmayer D; Weidemann S; Uhlig R; Huland H; Graefen M; Bernreuther C; Wittmer C; Tsourlakis MC; Minner S; Dum D; Hinsch A; Luebke AM; Simon R; Sauter G; Schlomm T; Möller K
BMC Cancer; 2020 Dec; 20(1):1220. PubMed ID: 33339518
[TBL] [Abstract][Full Text] [Related]
15. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
16. The Role of ESRP1 in the Regulation of PHGDH in Estrogen Receptor-Positive Breast Cancer.
Gökmen-Polar Y; Gu Y; Polar A; Gu X; Badve SS
Lab Invest; 2023 Mar; 103(3):100002. PubMed ID: 36925195
[TBL] [Abstract][Full Text] [Related]
17. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer.
Miano V; Ferrero G; Reineri S; Caizzi L; Annaratone L; Ricci L; Cutrupi S; Castellano I; Cordero F; De Bortoli M
Oncotarget; 2016 Jan; 7(3):3201-16. PubMed ID: 26621851
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis of PNN- and ESRP1-regulated alternative pre-mRNA splicing in human corneal epithelial cells.
Joo JH; Correia GP; Li JL; Lopez MC; Baker HV; Sugrue SP
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):697-707. PubMed ID: 23299472
[TBL] [Abstract][Full Text] [Related]
19. Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α.
Dou XW; Liang YK; Lin HY; Wei XL; Zhang YQ; Bai JW; Chen CF; Chen M; Du CW; Li YC; Tian J; Man K; Zhang GJ
Theranostics; 2017; 7(16):4041-4056. PubMed ID: 29109797
[TBL] [Abstract][Full Text] [Related]
20. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition.
Reinke LM; Xu Y; Cheng C
J Biol Chem; 2012 Oct; 287(43):36435-42. PubMed ID: 22961986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
